Concepedia

Publication | Open Access

The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

DOIFull Paper Access

240

Citations

32

References

2021

Year

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro, Lorenz Trümper, Swaminathan P. Iyer, Ranjana H. Advani, Nancy L. Bartlett, Jacob Haaber Christensen, F. Morschhauser, Eva Domingo‐Doménech,
Annals of Oncology

References

YearCitations

Page 1